BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 29664404)

  • 1. Outcomes in Patients With Hypertrophic Cardiomyopathy Awaiting Heart Transplantation.
    Zuñiga Cisneros J; Stehlik J; Selzman CH; Drakos SG; McKellar SH; Wever-Pinzon O
    Circ Heart Fail; 2018 Mar; 11(3):e004378. PubMed ID: 29664404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanical Circulatory Support Device Utilization and Heart Transplant Waitlist Outcomes in Patients With Restrictive and Hypertrophic Cardiomyopathy.
    Sridharan L; Wayda B; Truby LK; Latif F; Restaino S; Takeda K; Takayama H; Naka Y; Colombo PC; Maurer M; Farr MA; Topkara VK
    Circ Heart Fail; 2018 Mar; 11(3):e004665. PubMed ID: 29664407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The modified US heart allocation system improves transplant rates and decreases status upgrade utilization for patients with hypertrophic cardiomyopathy.
    Fowler CC; Helmers MR; Smood B; Iyengar A; Patrick W; Alan Herbst D; Altshuler P; Han JJ; Kelly J; Atluri P
    J Heart Lung Transplant; 2021 Oct; 40(10):1181-1190. PubMed ID: 34332861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does Survival on the Heart Transplant Waiting List Depend on the Underlying Heart Disease?
    Hsich EM; Rogers JG; McNamara DM; Taylor DO; Starling RC; Blackstone EH; Schold JD
    JACC Heart Fail; 2016 Sep; 4(9):689-97. PubMed ID: 27179836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morbidity and mortality in heart transplant candidates supported with mechanical circulatory support: is reappraisal of the current United network for organ sharing thoracic organ allocation policy justified?
    Wever-Pinzon O; Drakos SG; Kfoury AG; Nativi JN; Gilbert EM; Everitt M; Alharethi R; Brunisholz K; Bader FM; Li DY; Selzman CH; Stehlik J
    Circulation; 2013 Jan; 127(4):452-62. PubMed ID: 23271796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival after cardiac transplantation in patients with hypertrophic cardiomyopathy.
    Maron MS; Kalsmith BM; Udelson JE; Li W; DeNofrio D
    Circ Heart Fail; 2010 Sep; 3(5):574-9. PubMed ID: 20736440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changing outcomes after heart transplantation in patients with amyloid cardiomyopathy.
    Davis MK; Lee PH; Witteles RM
    J Heart Lung Transplant; 2015 May; 34(5):658-66. PubMed ID: 25444369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Waitlist and Posttransplant Outcomes of Children and Young Adults With Hypertrophic Cardiomyopathy.
    Cheong D; Eisenberg R; Lamour JM; Hsu DT; Choi J; Bansal N
    Ann Thorac Surg; 2023 Sep; 116(3):588-597. PubMed ID: 35690136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left ventricular assist device therapy in patients with restrictive and hypertrophic cardiomyopathy.
    Topilsky Y; Pereira NL; Shah DK; Boilson B; Schirger JA; Kushwaha SS; Joyce LD; Park SJ
    Circ Heart Fail; 2011 May; 4(3):266-75. PubMed ID: 21303989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the new heart allocation policy on patients with restrictive, hypertrophic, or congenital cardiomyopathies.
    Chouairi F; Mullan CW; Sen S; Mori M; Fuery M; Elder RW; Lesse J; Norton K; Clark KA; Miller PE; Mulligan D; Formica R; Rogers JG; Jacoby D; Maulion C; Anwer M; Geirsson A; Desai NR; Ahmad T
    PLoS One; 2021; 16(3):e0247789. PubMed ID: 33651802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival benefit from transplantation in patients listed for heart transplantation in the United States.
    Singh TP; Milliren CE; Almond CS; Graham D
    J Am Coll Cardiol; 2014 Apr; 63(12):1169-1178. PubMed ID: 24462511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of children with cardiomyopathy listed for transplant: a multi-institutional study.
    Dipchand AI; Naftel DC; Feingold B; Spicer R; Yung D; Kaufman B; Kirklin JK; Allain-Rooney T; Hsu D;
    J Heart Lung Transplant; 2009 Dec; 28(12):1312-21. PubMed ID: 19782592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices.
    Kamdar F; John R; Eckman P; Colvin-Adams M; Shumway SJ; Liao K
    J Thorac Cardiovasc Surg; 2013 Feb; 145(2):575-81. PubMed ID: 23321132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing outcomes for infiltrative and restrictive cardiomyopathies under the new heart transplant allocation system.
    Griffin JM; DeFilippis EM; Rosenblum H; Topkara VK; Fried JA; Uriel N; Takeda K; Farr MA; Maurer MS; Clerkin KJ
    Clin Transplant; 2020 Dec; 34(12):e14109. PubMed ID: 33048376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current outcomes in US children with cardiomyopathy listed for heart transplantation.
    Singh TP; Almond CS; Piercey G; Gauvreau K
    Circ Heart Fail; 2012 Sep; 5(5):594-601. PubMed ID: 22899768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in heart transplant waitlist and posttransplant outcomes in patients with restrictive and hypertrophic cardiomyopathy with the new heart transplant allocation system.
    Loyaga-Rendon RY; Fermin D; Jani M; Gonzalez M; Grayburn R; Lee S; Dickinson MG; Manandhar-Shrestha NK; Boeve T; Jovinge S; Leacche M
    Am J Transplant; 2021 Mar; 21(3):1255-1262. PubMed ID: 32978873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Waitlist Outcomes in Candidates With Rare Causes of Heart Failure After Implementation of the 2018 French Heart Allocation Scheme.
    Legeai C; Coutance G; Cantrelle C; Jasseron C; Para M; Sebbag L; Battistella P; Kerbaul F; Dorent R
    Circ Heart Fail; 2024 Feb; 17(2):e010837. PubMed ID: 38299331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Waitlist and transplant outcomes in heart transplant candidates bridged with temporary endovascular right ventricular assist devices.
    Kwon JH; Skidmore SH; Bhandari K; Carnicelli AP; Yourshaw JP; Shorbaji K; Kilic A
    J Heart Lung Transplant; 2024 Mar; 43(3):369-378. PubMed ID: 37951321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Waitlist and Post-Heart Transplant Outcomes for Children With Nondilated Cardiomyopathy.
    Amdani S; Boyle G; Saarel EV; Godown J; Liu W; Worley S; Karamlou T
    Ann Thorac Surg; 2021 Jul; 112(1):188-196. PubMed ID: 32768427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is Myocarditis an Independent Risk Factor for Post-Transplant Mortality in Pediatric Heart Transplant Recipients?
    Garbern JC; Gauvreau K; Blume ED; Singh TP
    Circ Heart Fail; 2016 Jan; 9(1):e002328. PubMed ID: 26699389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.